Freeline Therapeutics Holdings plc Quarterly Common Stock, Shares, Issued from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Freeline Therapeutics Holdings plc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q3 2023.
  • Freeline Therapeutics Holdings plc Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 65.4M shares, a 0.61% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 65.4M +394K +0.61% Sep 30, 2023 6-K 2023-12-01
Q2 2023 65.4M +397K +0.61% Jun 30, 2023 6-K 2023-08-15
Q1 2023 65.2M +2.81M +4.5% Mar 31, 2023 6-K 2023-05-30
Q4 2022 65.1M +29.3M +81.6% Dec 31, 2022 6-K 2023-12-01
Q3 2022 65M +29.2M +81.4% Sep 30, 2022 6-K 2022-11-15
Q2 2022 65M +29.2M +81.5% Jun 30, 2022 6-K 2022-08-09
Q1 2022 62.3M +26.5M +73.9% Mar 31, 2022 6-K 2022-05-10
Q4 2021 35.9M -354 0% Dec 31, 2021 20-F 2023-04-04
Q3 2021 35.8M Sep 30, 2021 6-K 2021-11-09
Q2 2021 35.8M +23.9M +201% Jun 30, 2021 6-K 2021-08-16
Q1 2021 35.8M Mar 31, 2021 6-K 2021-05-17
Q4 2020 35.9M +23.8M +198% Dec 31, 2020 20-F 2022-03-31
Q2 2020 11.9M Jun 30, 2020 6-K 2020-10-29
Q4 2019 12M Dec 31, 2019 6-K 2020-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.